Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1900114	MGD013注射液	tebotelimab	Injection	Biological Products	Import Drug Application	2019-11-16	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2019-11-15	view
JYSB2000090	MGD013注射液	tebotelimab	Injection	Biological Products	Supplementary Application	2020-03-27	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2020-03-26	view
JXSB2000049	MGD013注射液	tebotelimab	Injection	Biological Products(1)	Supplementary Application	2020-12-16			In Review	2021-05-09	view
JXSL1900135	MGD013注射液	tebotelimab	Injection	Biological Products	Import Drug Application	2019-11-29	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2019-11-28	view
JXSB2000008	MGD013注射液	tebotelimab	Injection	Biological Products(1)	Supplementary Application	2020-08-21			In Review	2020-08-19	view
JXSL1900134	MGD013注射液	tebotelimab	Injection	Biological Products	Import Drug Application	2019-11-29	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2019-11-28	view
JXSL1900116	MGD013注射液	tebotelimab	Injection	Biological Products	Import Drug Application	2019-11-28	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2019-11-27	view
JXSL2000031	MGD013注射液	tebotelimab	Injection	Biological Products	Import Drug Application	2020-04-01	再鼎医药（上海）有限公司	Zai Lab (Shanghai) Co Ltd	In Review	2020-03-31	view